TITLE:
Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

CONDITION:
Chronic Kidney Failure

INTERVENTION:
Rapamune

SUMMARY:

      The incidence of efficacy failure at 12 months between two regimens.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to N/A
Criteria:

        Inclusion Criteria

          -  Age: 13 years or older, 40 kgs or more

          -  End-stage renal disease

          -  African-American/Black transplant recipient and/or repeat renal transplant recipient
             who lost a previous allograft

        Exclusion Criteria

          -  Evidence of active infection

          -  Evidence abnormal chest x-ray

          -  Patients with HIV.
      
